Australia · Company Research
OncoSil jumps as trial data puts the FDA pathway back in focus
Small-cap healthcare rallies often begin with a single announcement. OncoSil Medical (ASX:OSL) gave the market three. The pancreatic cancer device company stood out on the ASX today after…
